Publication date: Jul 17, 2023
The Covid-19 pandemic drastically changed the way people work. This was no exception in the drug development industry, which like other industries has been grappling with the challenge of how to manage the transition back to the office while ensuring that people feel included. To understand what strategies organizations in the drug development industry are adopting and examine their impact on the employee experience, Tufts Center for the Study of Drug Development launched a survey that quantified the different strategies and their effect on work outcomes, including burnout, inclusion, and turnover. We found evidence that employees’ level of support for their organization’s remote work strategy had a significant impact on turnover, and this relationship was mediated by burnout and feeling of inclusion. Implications of the results are discussed.
| Concepts | Keywords |
|---|---|
| Covid | Burnout |
| Drug | Drug development |
| Employees | Inclusion |
| Launched | Remote work |
| Pandemic | Return to office |
| Turnover intention |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | organization |
| disease | MESH | Covid-19 pandemic |
| disease | MESH | burnout |